An immunotherapy treatment helps patients live years longer without their cancer getting worse or coming back, a major phase III trial has found. Pembrolizumab kept cancer at bay for some patients for ...

Scientists have worked out how a protective element of our DNA helps prevent an abnormal genetic event that can lead to cells becoming cancerous. They have shown exactly how telomeres – the protective ...

Despite significant advancements in cancer treatment, immunotherapy has shown limited success in treating prostate cancer due to the unique resistance mechanisms of its tumours. However, researchers ...

Our group's aim is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma. The goal of our laboratory is to improve the treatment and survival of ...

Blood cancer is an umbrella term for cancers affecting the blood, bone marrow or lymphatic system. Despite being a common cancer that can affect people of any age, it is often not very well understood ...

The goal of our laboratory is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma, three paediatric solid tumours in which high-risk patient ...

The largest study to date of most common form of testicular cancer has uncovered a possible link between disease risk and variations in the genes controlling cell shape and movement. By investigating ...

A recent study on an aggressive type of brain cancer has significantly advanced the understanding of the spectrum of tumours that occur in teenagers and young adults (TYA). High-grade gliomas (HGGs) ...